Evidence map›Paper›PMID 40496006›Full record

ReviewThe mental health clinician2025

Evaluating the efficacy of blister packaging in improving medication adherence within psychiatry: A systematic literature review.

Eric P Borrelli, Monica Telinoiu, Peter Saad, Nathan Barnes, Heather Nelkin, Julia D Lucaci

Abstract readReview
In one paragraph

Review in The mental health clinician, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Qualitative study of blister pack use during buprenorphine low dose initiation.Journal of the American Pharmacists Association : JAPhA
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eric P Borrelli(Corresponding author) Manager, Health Economics & Outcomes Research, Becton, Dickinson and Company; San Diego, California, ericborrelli@gmail.com.ORCID https://orcid.org/0000-0002-9941-9893
Monica TelinoiuSenior Manager, Health Economics & Outcomes Research Center of Excellence, Becton, Dickinson and Company; Franklin Lakes, New Jersey.ORCID https://orcid.org/0009-0006-0614-9262
Peter SaadSenior Manager, Medical Affairs, Becton, Dickinson and Company; Durham, North Carolina.ORCID https://orcid.org/0009-0000-4758-139X
Nathan BarnesSenior Manager, Medical Affairs, Becton, Dickinson and Company; Durham, North Carolina.ORCID https://orcid.org/0009-0001-9135-5397
Heather NelkinAssociate Director, Evidence Generation, Medical Affairs, Becton, Dickinson and Company; San Diego, California.ORCID https://orcid.org/0009-0001-7756-0781
Julia D LucaciDirector and Cross-Business Unit Lead, Health Economics & Outcomes Research, Becton, Dickinson and Company; Franklin Lakes, New Jersey.ORCID https://orcid.org/0009-0004-9002-4600

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Medication nonadherence is a prevalent and significant public health issue in the United States, particularly among patients with psychiatric disorders. Blister packaging medications is one of the most widely recognized and validated strategies for enhancing medication adherence. Given the paramount importance of adherence in psychiatry and the demonstrated effectiveness of blister packaging in chronic disorders, it is imperative to evaluate its effect in this context. Methods: A systematic literature review was conducted in PubMed and Google Scholar in May 2024 to identify relevant studies assessing the effect of blister packaging on medication adherence, health outcomes, and health care costs in psychiatry. Studies were included if they provided quantitative data on the effects of blister packaging on medication adherence in psychiatry. A meta-analysis was not performed due to differences in definitions of adherence in the included studies. Results: The review included 3 clinical studies and 1 cost-utility analysis (CUA). All 3 clinical studies demonstrated that blister packaging improved medication adherence rates. However, minimal data was available regarding its effect on clinical or patient-reported outcomes. The CUA found that blister packaging was dominant (less costly and more effective) compared with standard vial packaging. Discussion: The evidence presented in this review substantiates the positive effect for blister packaging in a psychiatric population. Nevertheless, due to the limited scope and size of the studies reviewed, further research with larger sample sizes is needed to fully assess the broader effect of blister packaging on clinical outcomes and health care costs within psychiatry.

Indexed as

adherencebehavioral healthblister packagingcompliancehealth outcomesmedication adherence packagingmental health

Identifiers

PMID40496006
PMCPMC12148011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.